Parnax Lab (BOM:506128) ROCE %: 13.99% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506128 Parnax Lab Ltd BOM:506128
69 GF Score
Price ₹133.25
GF Value ₹149.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Parnax Lab ROCE %?

Parnax Lab BOM:506128 -2.32% 69 ROCE % is 13.99% as of Mar. 2026. GuruFocus rates BOM:506128 with a GF Score™ of 69/100 and a GF Value™ of ₹149.14 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Parnax Lab's annualized ROCE % for the quarter that ended in Mar. 2026 was 13.99%.

Parnax Lab  (BOM:506128) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Parnax Lab ROCE % Related Terms

Parnax Lab ROCE % Historical Data

* Premium members only.

The historical data trend for Parnax Lab's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parnax Lab ROCE % Chart

Parnax Lab Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.03 22.23 18.32 18.94 17.48

Parnax Lab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.12 19.67 21.39 15.29 13.99
BOM:506128
69GF Score
Parnax Lab Ltd BOM:506128
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parnax Lab ROCE % Calculation

Parnax Lab's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=216.165/( ( (1898.183 - 743.337) + (2276.297 - 958.477) )/ 2 )
=216.165/( (1154.846+1317.82)/ 2 )
=216.165/1236.333
=17.48 %

Parnax Lab's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=184.388/( ( (0 - 0) + (2276.297 - 958.477) )/ 1 )
=184.388/( ( 0 + 1317.82 )/ 1 )
=184.388/1317.82
=13.99 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.99% mean?
Parnax Lab (BOM:506128) has a ROCE % of 13.99% as of Mar. 2026.
Is Parnax Lab's ROCE % too high?
Parnax Lab's current ROCE % is 13.99%. The Drug Manufacturers industry median ROCE % is 7.03. Parnax Lab's value of 13.99% is 99% above this industry median. Overall, Parnax Lab has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Parnax Lab's ROCE % compare to ZTS?
Parnax Lab's ROCE % of 13.99% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Parnax Lab's value of 13.99% is 99% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Parnax Lab's current ROCE % of 13.99% is 99% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Parnax Lab's current ROCE % is 13.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parnax Lab stock overvalued right now?
Based on GuruFocus' analysis, Parnax Lab (BOM:506128) is currently considered Fairly Valued. The stock's GF Value™ is ₹149.14, compared to a current price of ₹133.25 — trading 10.7% below its estimated fair value. The current ROCE % is 13.99% and 99% above the Drug Manufacturers industry median of 7.03. Parnax Lab's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Parnax Lab (BOM:506128), the current ROCE % is 13.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Parnax Lab (BOM:506128) Overvalued in 2026?

Based on GuruFocus' analysis, Parnax Lab stock appears to be undervalued. The current stock price of ₹133.25 is trading 10.7% below its estimated GF Value™ of ₹149.14. GuruFocus considers Parnax Lab to be Fairly Valued.

Key valuation signals for BOM:506128:

  • ROCE %: 13.99%
  • GF Value™: ₹149.14 vs. price of ₹133.25 (10.7% below fair value)
  • GF Score™: 69/100 with 4 warning signs
  • Industry Position: 99% above the Drug Manufacturers median

No single metric tells the full story. See the BOM:506128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Parnax Lab Business Description

Address 104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.
69GF Score

Get the complete analysis for BOM:506128

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹133.25
Price
₹149.14
GF Value